 | Renishaw Diagnostics builds top class teamGlasgow, Scotland, 2 August 2011 Renishaw Diagnostics Ltd, the developers of the RenDx™ Multiplex Assay System for infectious disease research and diagnosis today announced that it has created another 8 jobs; almost a 30% increase on its current workforce. The company also announced that its diagnostics project leader, Dr Karen Fitchett, has passed the Lean Six Sigma Green Belt exam of the British Quality Foundation certification, one of the most prestigious management qualifications. In contrast to the almost daily news about tough economic and market conditions, the company is expanding and looking to recruit talented individuals across a range of disciplines. The current vacancies are for scientists, field application specialists, customer support and regulatory affairs personnel, but commercialisation of their first multiplex assay system will also require additional staff for technical support and R&D, sales & marketing, manufacturing & logistics, and office management. David Burns, CEO said, “We are very excited about our continued business expansion. The launch of our RenDx™ RUO Multiplex Assay System has been well received at conferences in Europe and the USA and we are exibiting at 6 more events this year. We are now building a dynamic support team to include scientific, commercial and administrative skills to ensure that our customers receive the very best service and support. But we are also keen to develop our staff and I'm particularly pleased by Karen's achievement. “The transition from an R&D company to a fully commercial organisation is a very challenging process and it is essential that we have the right people in place to make this happen and to complement our existing top talent staff. We are a very exciting and friendly company to work for and living and working in Scotland has many benefits and attractions”. Enquiries: Jim Greaves Ph.D, Head of Marketing (+44 141 5577900) About Renishaw Diagnostics LtdRenishaw Diagnostics Ltd, formerly D3 Technologies Ltd, was a Strathclyde University spin-out before being acquired by the Renishaw Group, which is a leading global supplier of engineering technologies, medical devices and Raman spectroscopy systems. It is focused on developing and commercialising its first in vitro diagnostic (IVD) and clinical research products, with the goal of establishing Renishaw Diagnostics as the premium provider of automated, multiplex, high sensitivity molecular diagnostics products for the detection of human infectious diseases. Renishaw Diagnostics has launched its first RenDx™ research-use-only (RUO) multiplex assay system and is working towards the obtaining of CE marking for the system as an in vitro medical device in Europe and clearance in the US. The Company is based in Glasgow, Scotland, and further information is available at www.renishawdiagnostics.com. |